Electronrx

Building Regulatory-Ready Digital Insights for Respiratory Care. electronRx delivers clinically-validated digital solutions for the real-time monitoring, management, and diagnosis of patients with COPD, Asthma, Interstitial Lung Disease and Pulmonary Hypertension. Our platform transforms respiratory drug development and commercialisation by enabling: Digital biomarkers to support clinical endpoints Remote phenotyping and patient stratification Real-world data for evidence generation Companion tools that improve engagement and outcomes We partner with pharmaceutical leaders to advance trials, uncover insights beyond the clinic, and enhance treatment impact across the respiratory pipeline.